Cargando…
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
Cardiovascular and metabolic disorders, such as hypertension, insulin resistance, dyslipidemia or obesity are linked with chronic low-grade inflammation and dysregulation of the renin–angiotensin system (RAS). Consequently, RAS inhibition by ACE inhibitors or angiotensin AT1 receptor (AT1R) blockers...
Autores principales: | Paulis, Ludovit, Foulquier, Sébastien, Namsolleck, Pawel, Recarti, Chiara, Steckelings, Ulrike Muscha, Unger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700059/ https://www.ncbi.nlm.nih.gov/pubmed/26631237 http://dx.doi.org/10.1007/s40265-015-0509-4 |
Ejemplares similares
-
AT(2) Receptor and Tissue Injury: Therapeutic Implications
por: Namsolleck, Pawel, et al.
Publicado: (2014) -
Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure
por: Danyel, Leon A, et al.
Publicado: (2013) -
Angiotensin AT(2) Receptor Stimulation Alleviates Collagen-Induced Arthritis by Upregulation of Regulatory T Cell Numbers
por: Sehnert, Bettina, et al.
Publicado: (2022) -
Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches
por: Unger, Thomas, et al.
Publicado: (2011) -
Prevention and Intervention Studies with Telmisartan, Ramipril and Their Combination in Different Rat Stroke Models
por: Thoene-Reineke, Christa, et al.
Publicado: (2011)